Are you Dr. Teichman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 10 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
631 Hillgirt Cir
Oakland, CA 94610Phone+1 510-208-1992- Is this information wrong?
Summary
- Dr. Sam Teichman, MD is a cardiologist in Oakland, California. He is currently licensed to practice medicine in California and Florida.
Education & Training
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1980
- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine
- Montefiore Medical Center/Albert Einstein College of Medicine (MHS)Fellowship, Cardiovascular Disease
Certifications & Licensure
- CA State Medical License 1988 - 2026
- FL State Medical License 2023 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor Start of enrollment: 2005 Nov 01
- A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure Start of enrollment: 2005 Nov 01
- Topical Alprostadil for Female Sexual Arousal Disorder Start of enrollment: 2004 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsNeutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies).Beth A Davison, Koji Takagi, Christopher Edwards, Kirkwood F Adams Jr, Javed Butler, Sean P Collins, Maria I Dorobantu, Justin A Ezekowitz, Gerasimos Filippatos, Barry...> ;The American Journal of Cardiology. 2022 Oct 1
- 44 citationsEffects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial.Adriaan A. Voors, Jean François Tamby, John G.F. Cleland, Michael J. Koren, Leslie B. Forgosh, Dinesh Gupta, Lars H. Lund, Albert Camacho, Ravi Karra, Henk P. Swart, P...> ;European Journal of Heart Failure. 2020 Sep 1
- 20 citationsEffects of serelaxin in patients admitted for acute heart failure: a meta‐analysisJohn R. Teerlink, Beth A. Davison, Gad Cotter, Aldo P. Maggioni, Naoki Sato, Ovidiu Chioncel, Georg Ertl, G. Michael Felker, Gerasimos Filippatos, Barry H. Greenberg, ...> ;European Journal of Heart Failure. 2020 Feb 1
- Join now to see all
Professional Memberships
- Member